Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 05-07-2019 |
Asset Class: Equity |
Benchmark: S&P BSE Healthcare TRI |
TER: 2.44% As on (31-08-2023) |
Status: Open Ended Schemes |
Minimum Investment: 1000.0 |
Minimum Topup: 1000.0 |
Total Assets: 520.73 Cr As on (31-08-2023) |
Turn over: 37% | Exit Load: Exit load of 1% if redeemed within 30 days. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Standard Deviation | 15.02 |
Sharpe Ratio | 0.61 |
Alpha | -1.65 |
Beta | 0.94 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
22.21%
Others
4.73%
Large Cap
39.13%
Mid Cap
33.91%
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund